Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flamen

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
World Journal of Hepatology|January 24, 2018
Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinomaMichael Vouche, Thierry Degrez, Fikri Bouazza, et al.
Surgical Neurology|February 21, 2006
Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patientsFrank Van Calenbergh, Nikolaas Vantomme, Patrick Flamen, et al.
International Journal of Oncology|April 6, 2006
18FDG PET in oncology: the best and the worst (Review)Tarik Belhocine, Karoline Spaepen, Michelle Dusart, et al.
Clinical Imaging|March 1, 2015
Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidanceMichael Vouche, Riad Salem, Frank H Miller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?Olga Vrieze, Karin Haustermans, Walter De Wever, et al.
EJNMMI Reports|July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myelomaWendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2019
Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRIStylianos Drisis, Mohammed El Adoui, Patrick Flamen, et al.
Breast Cancer Research and Treatment|April 15, 2014
A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant diseaseRobert Coleman, Anne-Kirsti Aksnes, Bjørn Naume, et al.
EJNMMI Physics|April 2, 2024
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using <sup>166</sup>Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imagingBenoît Collette, Marie Mannie-Corbisier, Ana-Maria Bucalau, et al.
EJNMMI Research|July 15, 2018
<sup>90</sup>Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancerHugo Levillain, Ivan Duran Derijckere, Gwennaëlle Marin, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
World Journal of Hepatology|January 24, 2018
Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinomaMichael Vouche, Thierry Degrez, Fikri Bouazza, et al.
Surgical Neurology|February 21, 2006
Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patientsFrank Van Calenbergh, Nikolaas Vantomme, Patrick Flamen, et al.
International Journal of Oncology|April 6, 2006
18FDG PET in oncology: the best and the worst (Review)Tarik Belhocine, Karoline Spaepen, Michelle Dusart, et al.
Clinical Imaging|March 1, 2015
Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidanceMichael Vouche, Riad Salem, Frank H Miller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?Olga Vrieze, Karin Haustermans, Walter De Wever, et al.
EJNMMI Reports|July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myelomaWendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2019
Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRIStylianos Drisis, Mohammed El Adoui, Patrick Flamen, et al.
Breast Cancer Research and Treatment|April 15, 2014
A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant diseaseRobert Coleman, Anne-Kirsti Aksnes, Bjørn Naume, et al.
EJNMMI Physics|April 2, 2024
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using <sup>166</sup>Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imagingBenoît Collette, Marie Mannie-Corbisier, Ana-Maria Bucalau, et al.
EJNMMI Research|July 15, 2018
<sup>90</sup>Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancerHugo Levillain, Ivan Duran Derijckere, Gwennaëlle Marin, et al.
Pageof 13